Table 1.
Baseline characteristics of postmenopausal women with breast cancer (N=81) enrolled in the Bone Health Study, Washington University School of Medicine, St. Louis
| Characteristic | ||
|---|---|---|
| Age, years | 56.1 (9.3) | |
| Body mass index (BMI), kg/m2 | 31.6 (5.0) | |
| 25–29.9 | 32 (39.5) | |
| 30–35 | 29 (35.8) | |
| >35 | 20 (24.7) | |
| T-score | 0.90 (1.7) | |
| Lumbar spine bone mineral density | 1.08 (0.2) | |
| Pelvis bone mineral density | 1.21 (0.2) | |
| Race | ||
| White | 71 (87.7) | |
| Black | 10 (12.3) | |
| Education | ||
| High school Graduate | 12 (14.8) | |
| Some College | 23 (28.4) | |
| College | 22 (27.2) | |
| Post-Graduate | 24 (29.6) | |
| Tumor Stage | ||
| Stage 1 | 24 (29.6) | |
| Stage 2 | 44 (54.3) | |
| Stage 3 | 13 (16.1) | |
| Tumor grade | ||
| Well differentiated | 18 (22.2) | |
| Moderately differentiated | 31 (38.3) | |
| Poorly differentiated | 27 (33.3) | |
| Unspecified | 5 (6.2) | |
| Treatment with Tamoxifen | ||
| Yes | 21 (25.9) | |
| No | 60 (74.1) | |
| Treatment with an Aromatase Inhibitor | ||
| Yes | 44 (54.3) | |
| No | 37 (45.7) | |
Continuous variables are presented as mean (standard deviation) and categorical variables are presented as frequency (percentages).